Similar articles

• Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.

  Hillner BE, Smith TJ. Hillner BE, et al. Semin Oncol. 1996 Apr;23(2 Suppl 5):25-30. Semin Oncol. 1996. PMID: 8610234
• Vinorelbine for non-small cell lung cancer.

  Piccirillo MC, Daniele G, Di Maio M, Bryce J, De Feo G, Del Giudice A, Perrone F, Morabito A. Piccirillo MC, et al. Expert Opin Drug Saf. 2010 May;9(3):493-510. doi: 10.1517/14740331003774078. Expert Opin Drug Saf. 2010. PMID: 20350282 Review.
• [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].

  Mornex F. Mornex F. Rev Pneumol Clin. 2002 Nov;58(5 Pt 2):3S37-41. Rev Pneumol Clin. 2002. PMID: 12538934 French. No abstract available.
• Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.

  Viallet J, Ayoub J, Rousseau P, Souhami L, Hohneker J, Shepherd F. Viallet J, et al. Semin Oncol. 1994 Oct;21(5 Suppl 10):64-71; discussion 71-2. Semin Oncol. 1994. PMID: 7973771 Review.
• Update: vinorelbine (navelbine) in non-small cell lung cancer.

  Crawford J. Crawford J. Semin Oncol. 1996 Apr;23(2 Suppl 5):2-7. Semin Oncol. 1996. PMID: 8610232 Review.